Cargando…

1539. Presence of mental health concerns is associated with poor adherence in people taking pre-exposure prophylaxis in real-world clinical practice in the United States

BACKGROUND: Pre-exposure prophylaxis (PrEP) is used to prevent HIV acquisition and is up to 99% effective when users are fully adherent. Research has shown an inverse relationship between mental health difficulties and PrEP adherence. This analysis aims to understand the real-world impact of mental...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hennessy, Fritha, Turner, Libby, Higgins, Victoria, Piercy, James, Holbrook, Tim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677574/ http://dx.doi.org/10.1093/ofid/ofad500.1374

Ejemplares similares

1560. Factors Driving Decisions in the use of HIV Pre-Exposure Prophylaxis: Data from a Real-World Study in the United States
por: Whiteside, Yohance, et al.
Publicado: (2023)

1610. Adherence to Antiretroviral Therapy and Its Effect on Quality of Life among Persons with HIV in the United States using Real-World Data
por: Hennessy, Fritha, et al.
Publicado: (2023)

Cartas y memorias, 1511-1539 /
por: Zuazo, Alonso de, 1466-1539
Publicado: (2000)

La imprenta en México, 1539-1821 : edición facsimilar
por: Medina, José Toribio, 1852-1930
Publicado: (1989)

Censura y teatro novohispano (1539-1822) : ensayos y antología de documentos /
Publicado: (1998)

Correction to Lancet Glob Health 2021; 9: e1539–52
Publicado: (2021)

Risk-Taking Behaviors and Adherence to HIV Pre-Exposure Prophylaxis in Users of Geosocial Networking Apps: Real-World, Multicenter Study
por: Wang, Hongyi, et al.
Publicado: (2020)

Correction: Risk-Taking Behaviors and Adherence to HIV Pre-Exposure Prophylaxis in Users of Geosocial Networking Apps: Real-World, Multicenter Study
por: Wang, Hongyi, et al.
Publicado: (2020)

MiR-1539 and Its Potential Role as a Novel Biomarker for Colorectal Cancer
por: Cui, Xueyang, et al.
Publicado: (2021)

1539. Diagnosis of Yersinia enterocolitica in Cancer Patients With Diarrhea in the Era of Molecular Diagnostics for Gastrointestinal Infections
por: Wang, Elizabeth, et al.
Publicado: (2018)

1539. Pilot Study of Sexual Networks and Sexually Transmitted Infection Risk in a Military Population
por: Rahman, Nazia, et al.
Publicado: (2020)

Andreas Vesalius Bruxellensis: The Bloodletting Letter of 1539. An Annotated Translation and Study of the Evolution of Vesalius's Scientific Development
por: Forbes, Thomas R.
Publicado: (1948)

COVID-19 outcomes in patients taking cardioprotective medications
por: Morrison, Fritha J., et al.
Publicado: (2022)

Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns
por: Tetteh, Raymond A., et al.
Publicado: (2017)

P1539: SEASONALITY OF HEALTHCARE RESOURCE UTILIZATION AMONG COLD AGGLUTININ DISEASE AMONG PATIENTS IN DENMARK: A RETROSPECTIVE ANALYSIS
por: Fryzek, J., et al.
Publicado: (2022)

1539. A Nine-Gene Blood-Based Signature Meets the World Health Organization Target Product Profiles for Diagnosis of Active Tuberculosis and Predicting Progression from Latent to Active Disease
por: Gupta, Sanjana, et al.
Publicado: (2022)

Unmet Needs in Real-World Advanced Therapy-Naïve and -Experienced Patients with Moderately to Severely Active Ulcerative Colitis in the United States
por: Afzali, Anita, et al.
Publicado: (2023)

Comment on: Rogers et al. Blood Pressure Trajectories Prior to Death in Patients With Diabetes. Diabetes Care 2011;34:1534–1539
por: van Hateren, K.J.J., et al.
Publicado: (2011)

Abstract: Efficacy and Safety of N1539, Intravenous Meloxicam, in a Phase 3 Study of Subjects with Moderate to Severe Pain Following Abdominoplasty
por: Bindewald, Matthew, et al.
Publicado: (2017)

Understanding Pre-Exposure Prophylaxis Adherence in Young Women in Kenya
por: Haberer, Jessica E., et al.
Publicado: (2022)

Response to Comment on: Rogers et al. Blood Pressure Trajectories Prior to Death in Patients With Diabetes. Diabetes Care 2011;34:1534–1539
por: Rogers, Mary A.M.
Publicado: (2011)

1539. Dalbavancin, Vancomycin, and Daptomycin Alone and in Combination with Cefazolin Against Vancomycin Intermediate-Resistant (VISA) and Daptomycin Non-Susceptible (DNS) Staphylococcus aureus
por: Abdul-Mutakabbir, Jacinda, et al.
Publicado: (2019)

Comparing Self-Report Pre-Exposure Prophylaxis Adherence Questions to Pharmacologic Measures of Recent and Cumulative Pre-Exposure Prophylaxis Exposure
por: Blumenthal, Jill, et al.
Publicado: (2019)

The Presence or Absence of Symptoms Among Cases of Urethral Gonorrhoea Occurring in a Cohort of Men Taking Human Immunodeficiency Virus Pre-exposure Prophylaxis in the PrEPX Study
por: Donovan, Lucy C, et al.
Publicado: (2021)

Adherence to Pre-Exposure Prophylaxis for HIV Prevention in a Clinical Setting
por: Montgomery, Madeline C., et al.
Publicado: (2016)

Malaria prophylaxis: taking aim at constantly moving targets.
por: Bia, F. J.
Publicado: (1992)

Knowledge, Indications and Willingness to Take Pre-Exposure Prophylaxis among Transwomen in San Francisco, 2013
por: Wilson, Erin C., et al.
Publicado: (2015)

Willingness to take and ever use of pre-exposure prophylaxis among female sex workers in Ghana
por: Guure, Chris, et al.
Publicado: (2022)

A Review of Pre-Exposure Prophylaxis Adherence among Female Sex Workers
por: Ghayda, Ramy Abou, et al.
Publicado: (2020)

Characteristics, clinical outcomes and patient-reported outcomes of patients with ulcerative colitis receiving tofacitinib: a real-world survey in the United States and five European countries
por: Armuzzi, Alessandro, et al.
Publicado: (2023)

Adherence to Antibiotic Prophylaxis in Children with Vesicoureteral Reflux
por: Rodriguez, Esequiel, et al.
Publicado: (2011)

Systematic Review of Migraine Prophylaxis Adherence and Persistence
por: Hepp, Zsolt, et al.
Publicado: (2014)

A systematic review of adherence to oral pre-exposure prophylaxis for HIV – how can we improve uptake and adherence?
por: Sidebottom, David, et al.
Publicado: (2018)

Repeated False-Positive HIV Test Results in a Patient Taking HIV Pre-Exposure Prophylaxis
por: Stekler, Joanne D, et al.
Publicado: (2018)

Knowledge of and willingness to take pre-exposure prophylaxis among men who have sex with men in Israel
por: Zohar, Mor, et al.
Publicado: (2021)

Qualitative Interviews to Support Development and Cognitive Debriefing of the Adelphi Adherence Questionnaire (ADAQ©): A Patient-Reported Measure of Medication Adherence Developed for Use in a Range of Diseases, Treatment Modalities, and Countries
por: Bentley, Sarah, et al.
Publicado: (2022)

Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study
por: Gasse, Brunelle, et al.
Publicado: (2013)

Adherence rates and risk factors for suboptimal adherence to secondary prophylaxis for rheumatic fever
por: Kevat, Priya M, et al.
Publicado: (2020)

P1539: INFECTION-RELATED MORTALITY CLINICAL-BIOLOGICAL SCORING SYSTEM (IRM-SCORE) AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A VALIDATION STUDY IN GITMO CENTRES
por: Clerici, Daniela, et al.
Publicado: (2023)

FEM-PrEP: Adherence Patterns and Factors Associated With Adherence to a Daily Oral Study Product for Pre-exposure Prophylaxis
por: Corneli, Amy L., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8te82ogedg1r0f8ras7s82foc0